Please provide your email address to receive an email when new articles are posted on . The FDA has granted conditional use with MRI to an implantable transvenous phrenic nerve stimulation therapy for ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved for whole-body MRI-conditional use.
Nyxoah receives FDA approval for full-body 1.5T and 3T MRI compatibility for the Genio® system to treat Obstructive Sleep Apnea (OSA) Mont-Saint-Guibert, Belgium – 9 th February 2021 – Nyxoah SA ...
Please provide your email address to receive an email when new articles are posted on . An analysis of more 800 MRI examinations shows the scans do not induce clinically significant functional changes ...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, ...
MARLTON, N.J., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced today it has received ...
A cohort study of more than 600 persons with non-magnetic resonance imaging (MRI)-conditional implantable cardioverter defibrillators (ICDs) found that these ICDs still appropriately treated detected ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results